论文部分内容阅读
上海中药制药二厂近年来特别重视科技档案工作,利用档案,从中找到销售额徘徊不前的原因,并作出调整产品结构的科学决策,取得了显著的经济效益。 原先,该厂的产品结构不够合理,产值大的产品亏损也大,盈利产品做不大,市场销路打不开,企业面临困境,企业职工议论纷纷,责怪科技人员拿不出象样的产品来。那么该厂究竟有没有适销对路、能级高、附加值高的产品呢?档案显示:该厂共有二百来个产品,有不少还是被列入医疗保险范围内的治疗品,还有药酒、生物制剂产品则是该厂的特色产品。由于种种原因,一些治疗品没有形成规模,甚至有的产品开发出来后还未投入生产就被束之高阁,这样,许多产品自然被排除在医疗保险范围之外,市场销路难以打开。而附加值高的生物制剂产品虽然长期
In recent years, Shanghai TCM Pharmaceutical Factory has placed special emphasis on scientific and technological archives, using archives to find the reasons for stagnant sales, and made scientific decisions to adjust the product structure, achieving remarkable economic benefits. Originally, the product structure of the plant was not reasonable enough. Large-value products suffered large losses. Profitable products did not do much. Market sales could not be opened. Enterprises faced difficulties. There were many discussions among company employees and they blamed scientific and technical personnel for not having a decent product. . Then, does the plant have any products that are marketable, high in energy, and have high added value? The file shows that the plant has 200 products, many of which are still included in the scope of medical insurance, and there are Medicinal wine and biological products are the specialty products of the plant. Due to various reasons, some therapeutic products have not formed scale, and even some products that have not been put into production after being developed have been put on the shelf. As a result, many products are naturally excluded from the scope of medical insurance, and it is difficult for the market to open up. While high value-added biologic products are long-term